tradingkey.logo

Cytek Biosciences Inc

CTKB
5.100USD
+0.030+0.59%
Close 12/26, 16:00ETQuotes delayed by 15 min
652.11MMarket Cap
LossP/E TTM

Cytek Biosciences Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
200.45M
3.85%
EPS(YoY)
-0.05
48.67%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its total revenue reached 200.45M, with a year-on-year change of 3.85%.

What is the Earnings Per Share (EPS) of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.046, with a year-on-year change of 48.67%.

What is the net income of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its net income was -6.02M, with a year-on-year change of 50.44%.

What is the net margin of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its net profit margin was -3.00%, with a year-on-year change of 52.28%.

What is the gross margin of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its gross margin was 55.43%, with a year-on-year change of -2.23%.

What is the debt-to-asset ratio of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its debt-to-asset ratio was 1.14%, with a year-on-year change of 155.33%.

What is the Return on Equity (ROE) of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its Return on Equity (ROE) was -1.53%, with a year-on-year change of 48.59%.

What is the Return on Assets (ROA) of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its Return on Assets (ROA) was -1.21%, with a year-on-year change of 49.45%.

What is the operating profit of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its operating profit was -20.52M, with a year-on-year change of 26.30%.

What are the current assets of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its current assets were 396.45M, with a year-on-year change of 1.12%.

What are the total assets of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its total assets of Cytek Biosciences Inc were 499.50M, with a year-on-year change of 1.02%.

What are the total liabilities of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its total liabilities of Cytek Biosciences Inc were 103.76M, with a year-on-year change of 2.34%.

What is the total equity of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its total equity of Cytek Biosciences Inc was 395.74M, with a year-on-year change of 0.68%.

What is the net operating income of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its net operating income of Cytek Biosciences Inc was -6.02M, with a year-on-year change of 50.44%.

What is the net investment of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its net investment of Cytek Biosciences Inc was -82.97M, with a year-on-year change of 11.63%.

What is the net financing of Cytek Biosciences Inc?

According to Cytek Biosciences Inc's FY2024 earnings report, its net financing of Cytek Biosciences Inc was -15.82M, with a year-on-year change of 62.16%.
KeyAI